University of Wisconsin, Carbone Cancer Center — Madison, Wisconsin

University of Wisconsin, Carbone Cancer Center is a clinical research site located in Madison, Wisconsin, United States 53792.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Wisconsin, Carbone Cancer Center has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Metastatic ER+ Breast Cancer, Advanced Renal Cell Carcinoma, Cancer.

Sponsors: TTC Oncology, LLC, Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA, Parabilis Medicines, Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Wisconsin, Carbone Cancer Center?

University of Wisconsin, Carbone Cancer Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Wisconsin, Carbone Cancer Center conducted?

University of Wisconsin, Carbone Cancer Center has 5 clinical trials on record, with 2 currently active. Their work covers Metastatic ER+ Breast Cancer, Advanced Renal Cell Carcinoma, Cancer.

Is University of Wisconsin, Carbone Cancer Center accredited by Crixeo Health?

Yes — University of Wisconsin, Carbone Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Wisconsin, Carbone Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.